Efavirenz
Efavirenz is listed in the FDA National Drug Code directory with 21 NDC codes, marketed under brand name including Efavirenz. Available dosage forms: tablet, film coated, tablet, capsule, powder.
Drug details
- Generic Name
- Efavirenz
- Brand Names
- Efavirenz
- Application Number
- ANDA077673
- Sponsor
- Aurobindo Pharma Limited
- NDC Codes
- 21
- Dosage Forms
- TABLET, FILM COATED, TABLET, CAPSULE, POWDER
- Routes
- ORAL
- Active Ingredients
- EFAVIRENZ
Indications and Usage
1 INDICATIONS & USAGE Efavirenz in combination with other antiretroviral agents is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and in pediatric patients at least 3 months old and weighing at least 3.5 kg. Efavirenz is a non-nucleoside reverse transcriptase inhibitor indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 infection in adults and in pediatric patients at least 3 months old and weighing at least 3.5 kg.( 1 )